Announcements

MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.

With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.

Sungkyunkwan University Joins MDPI’s Institutional Open Access Program

In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.

OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.

MDPI CEO Visits Seoul, Korea

In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.

Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."

Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”

For further inquiries, please contact our Seoul office directly.

About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.

We are thrilled to share the updated Exceptional Reviewers List 2024. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to recent surveys conducted in 2023, 91% of our authors rate the peer review as good or excellent, thanks to our pool of excellent reviewers.

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in the Journal of Clinical Medicine’s peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.

The Exceptional Reviewers List was introduced in 2024. Each quarter, we will be selecting a group of outstanding reviewers and introduce them here.

Q2:

Name: Dr. Yuri P. Matusov
Affiliation: Division of Pulmonary & Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Interests: pulmonary hypertension; pulmonary vascular disease; pulmonary embolism; shock resuscitation; ARDS

Name: Dr. Yuko Ono
Affiliation: Department of Disaster and Emergency Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan
Interests: trauma; airway management; sepsis

Name: Dr. Adam Buckholz
Affiliation: Division of Gastroenterology and Hepatology, Presbyterian-Weill Cornell Medical College, New York, NY, USA
Interests: autoimmune hepatitis; cirrhosis; fatty liver disease; general hepatology; hepatitis B; hepatitis C

Name: Dr. Baptiste Demey
Affiliation: Department of Virology, CHU Amiens-Picardie, Amiens, France
Interests: virology; infectious disease; polyomavirus

Q1:

Name: Dr. Carlos Rodríguez-López
Affiliation: Teaching and Research in Neurorrehabilitation, Lecturer University Schools Gimbernat, University of Cantabria, La Coruña, Spain
Interests: peripheral nerve disorders and neuropathic behaviour; pain in neurological patients; therapeutic exercise in neurorehabilitation; - perceptual disorders after a central lesion; robotics and technology in neurorehabilitation
Interview: “As a lecturer and clinician my main interest when reviewing papers is to be updated in the neurorehabilitation field, and help through my contribution to set the standards concerning solutions for people who had suffered a lesion to their nervous system. Also, I´m very much interested in papers offering different ways to understand common signs and symptoms in the field, such as spasticity or neuropathic behaviour in such conditions, as I strongly believe that understanding peripheral nerve adaptations after a neurological disorder onset can shine a light on perceptual and motor alterations we see in the clinical setting. The review process allows me, also, to have a broader look on my field and to get in touch with researchers worldwide, with different points of view, opening my clinical reasoning to new perspectives in neurorrehabilitation.”

Name: Dr. Shiqi Ling
Affiliation: Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
Interests: Treatment and surgery of children's eye diseases; treatment and surgery of strabismus, amblyopia, and myopia; diagnosis and treatment of ocular surface diseases; corneal transplantation; amniotic membrane transplantation; limbal stem cells transplantation

Name: Prof. Dr. Gianluca Manni
Affiliation: Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università degli Studi di Roma, Tor Vergata, Roma, Lazio, Italy
Interests: glaucoma; clinical ophthalmology; OCT; optical coherence tomography; visual field tests; optic disk; clinical pharmacology

Name: Dr. Eftihia Polyzogopoulou
Affiliation: Emergency Medicine Department, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece
Interests: heart failure; acute heart failure; acute myocardial infarction; cardiac imaging

We are pleased to announce that Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will be granting the Travel Award to junior scientists. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the JCM Editorial Board.

This award provides financial support for the winners to attend an international conference in the field of clinical medicine to be held in 2025, in order to hold a presentation, present a poster, or both.

Candidate requirements:

• Postdoctoral fellows or Ph.D. students;
• Plans to attend an international conference in 2025 (oral presentation or poster).

Required application documents:

• Information of the conference the applicant is planning to attend and the abstract that will be submitted;
• curriculum vitae and list of publications;
• Justification letter describing the focus of the research (max. 800 words);
• Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/Ph.D. student.

The winners will each be awarded CHF 800 and an electronic certificate.

Please submit your applications for the JCM 2025 Travel Award online by 31 October 2024. You can find more information about this award and how to nominate here. To request further information, please contact the JCM Editorial Office.

Journal of Clinical Medicine Editorial Office

We are pleased to announce that Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is now inviting nominations for the JCM 2024 Young Investigator Award. This prize will be given to one young investigator in recognition of their excellence in the field of clinical medicine. All the nominations will be assessed by an Award Evaluation Committee led by the Editor-in-Chief, Dr. Emmanuel Andrès.

The prize includes:

• CHF 2000;
• The option to publish one paper free of charge in JCM after peer review before the end of 2025;
• An electronic certificate.

Eligibility and requirements:

• The candidate must have received their Ph.D. no more than 10 years prior to 31 December 2024;
• The candidate must have produced ground-breaking research and made a significant contribution to the advancement of clinical medicine;
• The candidate must be nominated by senior scientists.

List of documents for nomination:

• Detailed curriculum vitae, including an updated publication list and a list of the researcher’s own research grants;
• Scanned copy of their doctorate certificate;
• Signed nomination letters from two established senior scientists.

Nomination deadline: 31 December 2024.

You can find more information about this award and how to nominate here. To request further information, please contact the JCM Editorial Office.

Journal of Clinical Medicine Editorial Office

The 2024 ASCO Annual Meeting will take you to discover state-of-the-art research, groundbreaking treatments, and visionary insights, igniting your passion for oncology. This year's program will feature over 200 sessions, complementing Dr. Lynn Schuchter’s Presidential theme “The Art and Science of Cancer Care: From Comfort to Cure”.

The following MDPI journals will be represented:

• Cancers;
• JPM;
• Pharmaceutics;
• Healthcare;
• JCM;
• CIMB;
• Medical Sciences;
• Clinics and Practice;
• Onco;
• Current Oncology;
• Dermato;
• Pharmacy;
• Biomedicines;
• Diseases;
• Immuno;
• Biologics;
• Vaccines;
• Diagnostics;
• Hemato;
• Venereology.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://conferences.asco.org/am/attend.

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four-day congress engaged in basic, preclinical and translational cancer research across a myriad of topics that is aiming to spotlight, inspire and unite the cancer research community to innovate, build knowledge, and create collaborations.

The following MDPI journals will be represented:

• Cancers;
• Cells;
• IJMS;
• Healthcare;
• JCM;
• CIMB;
• Medical Sciences;
• Clinics and Practice;
• Onco;
• JMP;
• Current Oncology.

If you are attending this conference, please feel free to contact us online. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following link: https://2024.eacr.org/.

We are pleased to invite you to read the ten selected papers in 2023 in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). The list of relevant papers can be seen below.

1. “Do Insomnia Treatments Improve Daytime Function?”
by Nathaniel F. Watson, Suzanne M. Bertisch, Charles M. Morin, Rafael Pelayo, John W. Winkelman, Phyllis C. Zee and Andrew D. Krystal
J. Clin. Med. 2023, 12(9), 3089; https://doi.org/10.3390/jcm12093089
Available online: https://www.mdpi.com/2077-0383/12/9/3089

2. “What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?”
by Charles M. Morin, Suzanne M. Bertisch, Rafael Pelayo, Nathaniel F. Watson, John W. Winkelman, Phyllis C. Zee and Andrew D. Krystal
J. Clin. Med. 2023, 12(5), 1975; https://doi.org/10.3390/jcm12051975
Available online: https://www.mdpi.com/2077-0383/12/5/1975

3. “Management and Prognosis of Acute Stroke in Atrial Fibrillation”
by Mette F. Hindsholm, Dorte Damgaard, M. Edip Gurol, David Gaist and Claus Z. Simonsen
J. Clin. Med. 2023, 12(17), 5752; https://doi.org/10.3390/jcm12175752
Available online: https://www.mdpi.com/2077-0383/12/17/5752

4. “Introducing Machine Perfusion into Routine Clinical Practice for Liver Transplantation in the United States: The Moment Has Finally Come”
by Kristopher P. Croome
J. Clin. Med. 2023, 12(3), 909; https://doi.org/10.3390/jcm12030909
Available online: https://www.mdpi.com/2077-0383/12/3/909

5. “Diagnosis, Classification, and Assessment of the Underlying Etiology of Uveitis by Artificial Intelligence: A Systematic Review”
by Robin Jacquot, Pascal Sève, Timothy L. Jackson, Tao Wang, Antoine Duclos and Dinu Stanescu-Segall
J. Clin. Med. 2023, 12(11), 3746; https://doi.org/10.3390/jcm12113746
Available online: https://www.mdpi.com/2077-0383/12/11/3746

6. “Evidence-Based Approach of Biologic Therapy in Bronchial Asthma”
by Adnan Liaqat, Mathew Mason, Brian Foster, Grant Gregory, Avani Patel, Aisha Barlas, Sagar Kulkarni, Rafaela Basso, Pooja Patak, Hamza Liaqat et al.
J. Clin. Med. 2023, 12(13), 4321; https://doi.org/10.3390/jcm12134321
Available online: https://www.mdpi.com/2077-0383/12/13/4321

7. “Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease”
by Anjay Rastogi and James L. Januzzi, Jr.
J. Clin. Med. 2023, 12(8), 2824; https://doi.org/10.3390/jcm12082824
Available online: https://www.mdpi.com/2077-0383/12/8/2824

8. “Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia”
by Reed Mszar, Sarah Bart, Alexander Sakers, Daniel Soffer and Dean G. Karalis
J. Clin. Med. 2023, 12(4), 1382; https://doi.org/10.3390/jcm12041382
Available online: https://www.mdpi.com/2077-0383/12/4/1382

9. “Aerobic and Muscle-Strengthening Physical Activity, Television Viewing, and Nonalcoholic Fatty Liver Disease: The CARDIA Study”
by Daniel J. McDonough, Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Jr., Lisa B. VanWagner, John Jeffrey Carr, James G. Terry, Kelley Pettee Gabriel, Jared P. Reis et al.
J. Clin. Med. 2023, 12(17), 5603; https://doi.org/10.3390/jcm12175603
Available online: https://www.mdpi.com/2077-0383/12/17/5603

10. “Neuroworsening in the Emergency Department Is a Predictor of Traumatic Brain Injury Intervention and Outcome: A TRACK-TBI Pilot Study”
by John K. Yue, Nishanth Krishnan, John H. Kanter, Hansen Deng, David O. Okonkwo, Ava M. Puccio, Debbie Y. Madhok, Patrick J. Belton, Britta E. Lindquist, Gabriela G. Satris et al.
J. Clin. Med. 2023, 12(5), 2024; https://doi.org/10.3390/jcm12052024
Available online: https://www.mdpi.com/2077-0383/12/5/2024

You are invited to view and submit clinical papers to the journal at the following link: https://www.mdpi.com/journal/jcm.

JCM Editorial Office

MDPI will be attending the American Thoracic Society International Conference 2024, which will be held on from 17 to 22 May 2024 in San Diego, USA.

The ATS International Conference brings together pulmonary, critical care, and sleep professionals at all career stages, fostering collaboration and knowledge exchange. With nearly 14,000 attendees annually, the event serves as a platform for the latest research, global networking, and interdisciplinary discussions. Healthcare professionals from various fields, including nurses, therapists, and hospitalists, converge to share insights and advancements in pulmonary health, critical care, and sleep disorders. Furthermore, the conference's global reach is highlighted by 40 percent of participants representing healthcare facilities from around the world.

The following MDPI journals will be represented at the conference:

• Children;
• Medicina;
• Journal of Clinical Medicine;
• International Journal of Environmental Research and Public Health;
• Tomography;
• European Journal of Investigation in Health, Psychology and Education.

If you are considering attending this conference, we warmly welcome you to visit our booth and interact with our representatives. We are eager to meet you in person and assist you with any queries you may have. For more information about the conference, please visit the official website at https://conference.thoracic.org/.

We are pleased to announce the winners of the JCM 2023 Best Paper Award, who were chosen by a selection committee chaired by the Editor-in-Chief of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383), Prof. Dr. Emmanuel Andrès. Following a review process conducted by the Award Evaluation Committee, five winners were selected.

Each winner will receive CHF 500 and the chance to publish a paper in JCM in 2024, following peer review.

Articles:

“Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge”
by Modesto M. Maestre-Muñiz, Ángel Arias, Emilia Mata-Vázquez, María Martín-Toledano, Germán López-Larramona, Ana María Ruiz-Chicote, Bárbara Nieto-Sandoval and Alfredo J. Lucendo
J. Clin. Med. 2021, 10(13), 2945; https://doi.org/10.3390/jcm10132945

“Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection”
by Rosa Bellmann-Weiler, Lukas Lanser, Robert Barket, Lukas Rangger, Anna Schapfl, Marc Schaber, Gernot Fritsche, Ewald Wöll and Günter Weiss
J. Clin. Med. 2020, 9(8), 2429; https://doi.org/10.3390/jcm9082429

Reviews:

“Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417

“Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations”
by Laura Dresser, Richard Wlodarski, Kourosh Rezania and Betty Soliven
J. Clin. Med. 2021, 10(11), 2235; https://doi.org/10.3390/jcm10112235

“Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442

Please join us in congratulating the winners of the JCM 2023 Best Paper Award. We would also like to thank all our authors for their continued support of JCM. You can access more awards information via the following link: https://www.mdpi.com/journal/jcm/awards.

JCM Editorial Office